Cornerstone Planning Group
RVMD icon

Cornerstone Planning Group’s Revolution Medicines RVMD Stock Holding History

Cornerstone Planning Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-199
Closed -$36.4K – 1378
2026
Q2 		$36.4K Buy
199
+5
+3% +$730 ﹤0.01% 481
2026
Q1 		$28.6K Buy
194
+184
+1,840% +$18.6K ﹤0.01% 554
2025
Q4 		$973 Sell
10
-9
-47% -$590 ﹤0.01% 1351
2025
Q3 		$1.73K Buy
19
+9
+90% +$352 ﹤0.01% 1197
2025
Q2 		$384 Hold
10
– – ﹤0.01% 1374
2025
Q1 		$374 Buy
+10
New +$406 ﹤0.01% 1369

Other funds holding RVMD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Loftus Peak Pty Ltd
Loftus Peak Pty Ltd Sydney, Australia $781M AUM
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Wedmont Private Capital
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Cornerstone Planning Group's RVMD Position: Q3 2026 in Review

Cornerstone Planning Group sold out of Revolution Medicines (RVMD) in Q3 2026, closing a stake of 199 shares — an estimated $36.4K sold.

Cornerstone Planning Group first reported a position in RVMD in Q1 2025 and held it in 6 quarters. The position peaked at $36.4K in Q2 2026. 146 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Cornerstone Planning Group reported no remaining Revolution Medicines position as of Q3 2026 after selling out during the quarter.
  • Cornerstone Planning Group sold 199 Revolution Medicines shares in Q3 2026, an estimated $36.4K.
  • Cornerstone Planning Group first reported a position in Revolution Medicines in Q1 2025 and held it in 6 quarters.
  • Cornerstone Planning Group's Revolution Medicines position peaked at $36.4K in Q2 2026.
  • 146 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Cornerstone Planning Group's 13F filing for Q3 2026, filed 16 Oct 2026.